Table 1.

Clinicopathological data

ER status
Positive (%)	47 (65.3)
Negative (%)	18 (25.0)
Weak (%)	5 (6.9)
Unknown (%)	2 (2.8)
PR status
Positive (%)	35 (48.6)
Negative (%)	25 (34.7)
Weak (%)	2 (2.8)
Unknown (%)	10 (13.9)
HER2 status
Positive (%)	14 (19.4)
Negative (%)	54 (75.0)
Weak (%)	2 (2.8)
Unknown (%)	2 (2.8)
Subtypes of breast cancer
Luminal carcinomas (%)	42 (63.6)
Triple-Negative tumors (%)	10 (15.2)
HER2-enriched tumors (%)	14 (21.2)